Fragment Screening of MIF by Surface Plasmon Resonance

Area of Science:

• Biochemistry
• Immunology
• Drug Discovery

Background:

• Macrophage migration inhibitory factor (MIF) is a key cytokine in autoimmune diseases, inflammation, and cancer.
• MIF's involvement in disease pathogenesis makes it a significant therapeutic target.
• Small-molecule inhibitors of MIF are crucial for understanding its immune functions and developing new treatments.

Purpose of the Study:

• To develop and validate a reliable surface plasmon resonance (SPR) assay for MIF.
• To establish conditions for immobilizing stable and active MIF for SPR analysis.
• To provide a method for screening and validating small-molecule fragments that bind to MIF.

Main Methods:

• Utilized surface plasmon resonance (SPR) for high-throughput screening of small organic compounds (fragments).
• Determined binding kinetics (K_A, K_D) and equilibrium constants for MIF-fragment interactions.
• Correlated SPR binding data with functional inhibitory activity (IC₅₀) from cell-based assays.

Main Results:

• Successfully established a robust SPR assay for MIF, enabling protein immobilization and stability.
• Demonstrated the utility of SPR for quantifying MIF-fragment binding interactions.
• Provided a method to validate compound binding and identify potential false positives.

Conclusions:

• The developed SPR assay is a valuable tool for MIF inhibitor drug discovery.
• This method facilitates the elucidation of MIF's biological roles.
• Optimized SPR conditions are essential for reliable fragment screening and therapeutic development.